Access the full text.
Sign up today, get DeepDyve free for 14 days.
AG Bostom, LA Cupples, JL Jenner, JM Ordovas, LJ Seman, PW Wilson, EJ Schaefer, WP Castelli (1996)
Elevated plasma lipoprotein(a) and coronary heart disease in men aged 55 years and younger. A prospective studyJAMA, 276
J Frohlich, M Dobiasova, L Adler, M Francis (2004)
Gender differences in plasma levels of lipoprotein (a) in patients with angiographically proven coronary artery diseasePhysiol Res, 53
J Pineda, F Marin, P Marco, V Roldan, J Valencia, JM Ruiz-Nodar, F Sogorb, GY Lip (2009)
Premature coronary artery disease in young (age < 45) subjects: interactions of lipid profile, thrombophilic and haemostatic markersInt J Cardiol, 136
CA Glader, LS Birgander, H Stenlund, GH Dahlen (2002)
Is lipoprotein(a) a predictor for survival in patients with established coronary artery disease? Results from a prospective patient cohort study in northern SwedenJ Intern Med, 252
JJ Genest, JR McNamara, DN Salem, EJ Schaefer (1991)
Prevalence of risk factors in men with premature coronary artery diseaseAm J Cardiol, 67
GH Dahlen, JR Guyton, M Attar, JA Farmer, JA Kautz, AM Gotto (1986)
Association of levels of lipoprotein Lp(a), plasma lipids, and other lipoproteins with coronary artery disease documented by angiographyCirculation, 74
P Cremer, D Nagel, B Labrot, H Mann, R Muche, H Elster, D Seidel (1994)
Lipoprotein Lp(a) as predictor of myocardial infarction in comparison to fibrinogen, LDL cholesterol and other risk factors: results from the prospective Gottingen Risk Incidence and Prevalence Study (GRIPS)Eur J Clin Invest, 24
A Imhof, D Rothenbacher, N Khuseyinova, A Hoffmeister, W Maerz, M Nauck, H Scharnagl, W Koenig, H Brenner (2003)
Plasma lipoprotein Lp(a), markers of haemostasis and inflammation, and risk and severity of coronary heart diseaseEur J Cardiovasc Prev Rehabil, 10
SH Golden, AR Folsom, J Coresh, AR Sharrett, M Szklo, F Brancati (2002)
Risk factor groupings related to insulin resistance and their synergistic effects on subclinical atherosclerosis: the atherosclerosis risk in communities studyDiabetes, 51
SJ Nicholls, WH Tang, H Scoffone, DM Brennan, J Hartiala, H Allayee, SL Hazen (2010)
Lipoprotein(a) levels and long-term cardiovascular risk in the contemporary era of statin therapyJ Lipid Res, 51
J Genest, JR McNamara, JM Ordovas, JL Jenner, SR Silberman, KM Anderson, PW Wilson, DN Salem, EJ Schaefer (1992)
Lipoprotein cholesterol, apolipoprotein A-I and B and lipoprotein (a) abnormalities in men with premature coronary artery diseaseJ Am Coll Cardiol, 19
G Luc, JM Bard, D Arveiler, J Ferrieres, A Evans, P Amouyel, JC Fruchart, P Ducimetiere (2002)
Lipoprotein (a) as a predictor of coronary heart disease: the PRIME StudyAtherosclerosis, 163
PM Ridker, CH Hennekens, MJ Stampfer (1993)
A prospective study of lipoprotein(a) and the risk of myocardial infarctionJAMA, 270
AD Tselepis, M Elisaf, J Goudevenos, T Tselegaridis, E Bairaktari, KC Siamopoulos, D Sideris (1996)
Lipid profile in patients with microvascular anginaEur J Clin Invest, 26
K Berg, G Dahlen, B Christophersen, T Cook, J Kjekshus, T Pedersen (1997)
Lp(a) lipoprotein level predicts survival and major coronary events in the Scandinavian Simvastatin Survival StudyClin Genet, 52
C Mestre, A Grand, Y Fournis, N Mamelle, E Landrault, N Cambrillat (1998)
[The importance of lipoprotein(a) as a predictive factor of coronary atherosclerosis]Presse Med, 27
T Murase, M Okubo, M Amemiya-Kudo, T Hiraga, J Oka, M Shimada, T Igarashi (2007)
Impact of markedly elevated serum lipoprotein(a) levels (> or = 100 mg/dL) on the risk of coronary heart diseaseMetabolism, 56
LJ Seman, C DeLuca, JL Jenner, LA Cupples, JR McNamara, PW Wilson, WP Castelli, JM Ordovas, EJ Schaefer (1999)
Lipoprotein(a)-cholesterol and coronary heart disease in the Framingham Heart StudyClin Chem, 45
A Eckardstein, H Schulte, P Cullen, G Assmann (2001)
Lipoprotein(a) further increases the risk of coronary events in men with high global cardiovascular riskJ Am Coll Cardiol, 37
PR Kamstrup, A Tybjaerg-Hansen, R Steffenssen (2009)
Genetically elevated lipoprotein(a) and increased risk of myocardial infarctionJAMA, 301
J Leebmann, E Roeseler, U Julius, F Heigl, R Spitthoever, D Heutling, P Breitenberger, W Maerz, W Lehmacher, A Heibges, R Klingel (2013)
Lipoprotein apheresis in patients with maximally tolerated lipid-lowering therapy, lipoprotein(a)-hyperlipoproteinemia, and progressive cardiovascular disease: prospective observational multicenter studyCirculation, 128
M Seed, KL Ayres, SE Humphries, GJ Miller (2001)
Lipoprotein (a) as a predictor of myocardial infarction in middle-aged menAm J Med, 110
G Gaeta, S Cuomo, G Capozzi, MC Foglia, S Barra, A Madrid, V Stornaiuolo, M Trevisan (2008)
Lipoprotein(a) levels are increased in healthy young subjects with parental history of premature myocardial infarctionNutr Metab Cardiovasc Dis, 18
I Shai, MB Schulze, JE Manson, MJ Stampfer, N Rifai, FB Hu (2005)
A prospective study of lipoprotein(a) and risk of coronary heart disease among women with type 2 diabetesDiabetologia, 48
PR Kamstrup, M Benn, A Tybjaerg-Hansen, BG Nordestgaard (2008)
Extreme lipoprotein(a) levels and risk of myocardial infarction in the general population: the Copenhagen City Heart StudyCirculation, 117
EJ Schaefer, S Lamon-Fava, JL Jenner, JR McNamara, JM Ordovas, CE Davis, JM Abolafia, K Lippel, RI Levy (1994)
Lipoprotein(a) levels and risk of coronary heart disease in men. The lipid Research Clinics Coronary Primary Prevention TrialJAMA, 271
F Ashfaq, PK Goel, R Sethi, MI Khan, W Ali, MZ Idris (2013)
Lipoprotein(a) levels in relation to severity of coronary artery disease in north indian patientsHeart Views, 14
V Salomaa, V Rasi, J Pekkanen, E Vahtera, M Jauhiainen, E Vartiainen, G Myllyla, C Ehnholm (1994)
Haemostatic factors and prevalent coronary heart disease; the FINRISK Haemostasis StudyEur Heart J, 15
E Ornek, S Murat, M Duran, M Turfan, A Kurtul, MB Demircelik, MA Vatankulu, H Ocek, R Akdemir (2011)
The relationship between lipoprotein(a) and coronary artery disease, as well as its variable nature following myocardial infarctionClin Invest Med, 34
RA Schwartzman, ID Cox, J Poloniecki, R Crook, CA Seymour, JC Kaski (1998)
Elevated plasma lipoprotein(a) is associated with coronary artery disease in patients with chronic stable angina pectorisJ Am Coll Cardiol, 31
HW Hahmann, D Schätzer-Klotz, T Bunte (1999)
The significance of high levels of lipoprotein(a) compared with etablished risk factors in premature coronary artery disease. Diffrences between men and womanAtherosclerosis, 144
C Buechler, H Ullrich, C Aslanidis, SM Bared, A Lingenhel, M Ritter, G Schmitz (2003)
Lipoprotein (a) downregulates lysosomal acid lipase and induces interleukin-6 in human blood monocytesBiochim Biophys Acta, 1642
BG Nordestgaard, MJ Chapman, K Ray, J Boren, F Andreotti, GF Watts, H Ginsberg, P Amarenco, A Catapano, OS Descamps, E Fisher, PT Kovanen, JA Kuivenhoven, P Lesnik, L Masana, Z Reiner, MR Taskinen, L Tokgozoglu, A Tybjaerg-Hansen (2010)
Lipoprotein(a) as a cardiovascular risk factor: current statusEur Heart J, 31
K Berg (1963)
A new serum type system in man –the Lp SystemActa Pathol Microbiol Scand, 59
IC Klausen, A Sjol, PS Hansen, LU Gerdes, L Moller, L Lemming, M Schroll, O Faergeman (1997)
Apolipoprotein(a) isoforms and coronary heart disease in men: a nested case-control studyAtherosclerosis, 132
PJ Schreiner (1994)
Lipoprotein(a) as a risk factor for preclinical atherosclerotic disease in a biracial cohort: the Atherosclerosis Risk in Communities (ARIC) StudyChem Phys Lipids, 67–68
GT Jones, AM Rij, J Cole, MJ Williams, EH Bateman, SM Marcovina, M Deng, SP McCormick (2007)
Plasma lipoprotein(a) indicates risk for 4 distinct forms of vascular diseaseClin Chem, 53
JJ Genest, SS Martin-Munley, JR McNamara, JM Ordovas, J Jenner, RH Myers, SR Silberman, PW Wilson, DN Salem, EJ Schaefer (1992)
Familial lipoprotein disorders in patients with premature coronary artery diseaseCirculation, 85
HS Starkman, G Cable, V Hala, H Hecht, CM Donnelly (2003)
Delineation of prevalence and risk factors for early coronary artery disease by electron beam computed tomography in young adults with type 1 diabetesDiabetes Care, 26
A Onat, G Hergenc, H Ozhan, Z Kaya, S Bulur, E Ayhan, G Can (2008)
Lipoprotein(a) is associated with coronary heart disease independent of metabolic syndromeCoron Artery Dis, 19
J Genest, JL Jenner, JR McNamara, JM Ordovas, SR Silberman, PW Wilson, EJ Schaefer (1991)
Prevalence of lipoprotein (a) [Lp(a)] excess in coronary artery diseaseAm J Cardiol, 67
I Shai, EB Rimm, SE Hankinson, C Cannuscio, G Curhan, JE Manson, N Rifai, MJ Stampfer, J Ma (2005)
Lipoprotein (a) and coronary heart disease among women: beyond a cholesterol carrier?Eur Heart J, 26
T Murase, M Okubo, M Amemiya-Kudo, T Ebara, Y Mori (2008)
Impact of elevated serum lipoprotein (a) concentrations on the risk of coronary heart disease in patients with type 2 diabetes mellitusMetabolism, 57
M Catalano, E Perilli, G Carzaniga, F Colombo, M Carotta, S Andreoni (1998)
Lp(a) in hypertensive patientsJ Hum Hypertens, 12
Der klinischen Relevanz von Lipoprotein(a) [Lp(a)] als kardiovaskulärer Risikofaktor wird aktuell nur bedingt die notwendige Bedeutung beigemessen. Es gilt zu klären, welchen Einfluss erhöhte Lp(a)-Werte auf die Entstehung und den Schweregrad einer koronaren Herzkrankheit (KHK) hat.
Clinical Research in Cardiology Supplements – Springer Journals
Published: Feb 10, 2015
Read and print from thousands of top scholarly journals.
Already have an account? Log in
Bookmark this article. You can see your Bookmarks on your DeepDyve Library.
To save an article, log in first, or sign up for a DeepDyve account if you don’t already have one.
Copy and paste the desired citation format or use the link below to download a file formatted for EndNote
Access the full text.
Sign up today, get DeepDyve free for 14 days.
All DeepDyve websites use cookies to improve your online experience. They were placed on your computer when you launched this website. You can change your cookie settings through your browser.